EVIVE BIOTECH
Evive Biotech is a global biologics company with Asian roots, developing a portfolio of novel biological therapies for patients and healthcare professionals worldwide. We leverage our two proprietary technology platforms, DiKineโข and ITabโข, to advance a series of innovative drug candidates for oncology and inflammatory disorders. Founded in 2004, we have over 200 employees today with operations in the US, Singapore and China. We adopt a holistic approach to drug development, combining excep... tional research and commercialization capabilities with world class in-house regulatory expertise to bring innovative therapies to market quickly and efficiently. Our state-of-the-art in-house cGMP facility allows us to manufacture at commercial scale in accordance with FDA, EMA and NMPA standards and industry best practices. Through partnerships with industry, doctors, and regulators, we develop revolutionary remedies that we believe will make a real and lasting difference to patients and their families worldwide.
EVIVE BIOTECH
Social Links:
Industry:
Biotechnology
Founded:
2004-01-01
Address:
Singapore, Central Region, Singapore
Country:
Singapore
Website Url:
http://www.evivebiotech.com
Total Employee:
251+
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon WordPress Apache Wordpress Plugins Google Maps GoDaddy SSL Elementor Elementor Pro
Similar Organizations
BioNome
Biotechnology Company
Cellex
Biotechnology
Creo Ingredients
Biotechnology
EMBIO Diagnostics
Biotechnology and Hardware Development
Eversphere
Biotech, Agritech
LifeFoundry, Inc.
Automation of Biotechnology
Matลซ Group
Science and Technology
PARTURA Medical
A Biotechnology Company.
rBIO
Biotechnology
Shuimu BioSciences
Shuimu BioSciences provides one-stop solutions for cryo-EM-Powered drug discovery.
More informations about "Evive Biotech" on Search Engine
Evive Biotech: Develop Novel Therapies for Patients Worldwide
Evive Biotech and Acrotech Biopharma Announce FDA Approval of Ryzneuta® (Efbemalenograstim alfa Injection) for Chemotherapy-Induced Neutropenia (CIN) Nov โฆSee details»
Evive Biotech and Acrotech Biopharma Announce FDA Approval โฆ
Nov 22, 2023 Evive Biotech, a subsidiary of Yifan Pharma, is a global biopharmaceutical company devoted to developing a portfolio of novel biological therapies for patients โฆSee details»
Evive Biotech - Crunchbase Company Profile & Funding
Industries. Biotechnology. Headquarters Regions Asia-Pacific (APAC), Association of Southeast Asian Nations (ASEAN), Southeast Asia. Founded Date 2004. Operating โฆSee details»
Evive Biotech | LinkedIn
Evive Biotech is a global biopharmaceutical company devoted to developing a portfolio of novel biological therapies for patients worldwide. We leverage our proprietary technology platforms to...See details»
Evive Enters License Agreement with Acrotech Biopharma to โฆ
November 22, 2022, New Jersey โ Evive Biotech (Evive), a global biopharmaceutical company devoted to developing novel biologic therapies and a subsidiary of Yifan โฆSee details»
Evive Biotech Submits Biologics License Application to US FDA โฆ
SINGAPORE, March 31, 2021 /PRNewswire/ -- Evive Biotech, a global biologics company developing novel biologic therapies, today announced the submission of its Biologics โฆSee details»
Evive Biotech meets primary and secondary endpoints in global โฆ
Jul 07, 2020, 09:00 ET. Share this article. Safety and efficacy endpoints met successfully in pivotal trial for F-627 (efbemalenograstim alfa), a novel long-acting G-CSF. Key โฆSee details»
FDA Approves Ryzneuta (efbemalenograstim alfa) for โฆ
Nov 22, 2023 Evive Biotech, a subsidiary of Yifan Pharma, is a global biopharmaceutical company devoted to developing a portfolio of novel biological therapies for patients โฆSee details»
Evive Biotech (Shanghai) - PitchBook
Nov 7, 2013 Description. Developer of recombinant protein drugs designed for tumor and other autoimmune disease. The company focuses on researching and developing โฆSee details»
Nona Biosciences Announces Collaboration with Evive Biotech to ...
Dec 11, 2023 CAMBRIDGE, Mass., Dec. 10, 2023 /PRNewswire/ -- Nona Biosciences, a global pioneer of technology innovation and antibody discovery and development โฆSee details»
Evive Biotech | VentureRadar
Evive Biotech is a global biologics company focused on oncology, inflammatory and metabolic diseases. As the first biopharmaceutical company to build... ... Find out more โฆSee details»
Evive Biotech | Qualifyze
Description. Evive Biotech, a worldwide biologics organization with origins in Asia, is developing a range of innovative biological treatments for patients and healthcare โฆSee details»
A 319 - AdisInsight - Springer
May 10, 2024 Originator Evive Biotech. Class Antineoplastics; Bispecific antibodies; Immunotherapies. Mechanism of Action Immunomodulators. Orphan Drug Status. โฆSee details»
Evive Biotech | LinkedIn
Evive Biotech is a global biopharmaceutical company devoted to developing a portfolio of novel biological therapies for patients worldwide. We leverage our proprietary โฆSee details»
Evive Biotech Enters License Agreement with Acrotech โฆ
November 22, 2022, New Jersey โ Evive Biotech (Evive), a global biopharmaceutical company devoted to developing novel biologic therapies and a subsidiary of Yifan โฆSee details»
NewsDetails - Evive Biotech
About Evive Biotech. Evive Biotech is a global biologics company with Asian roots, developing a portfolio of novel biological therapies for patients and healthcare โฆSee details»
Evive Biotech - Crunchbase
Companies like Evive Biotech include Granata Bio, VIBRE, and PARTURA Medical. Kartos Therapeutics Redwood City , California , United States 74 Contacts 11-50 employeesSee details»
Evive Biotech and Acrotech Biopharma Announce FDA Approval โฆ
Evive Biotech, a subsidiary of Yifan Pharma, is a global biopharmaceutical company devoted to developing a portfolio of novel biological therapies for patients worldwide. We โฆSee details»
How will quantum impact the biotech industry? - IBM Blog
May 20, 2024 Biotech enterprises are using IBM Quantum Systems to run their workloads on real utility-scale quantum hardware, while leveraging the IBM Quantum Network to โฆSee details»
Biotech Advances in 2024: Innovative Treatments Aim to Boost
1 day ago VANCOUVER, BC, June 3, 2024 /CNW/ -- USA News Group โ Recognized as one of the most lethal cancers, researchers are striving to improve survival rates for โฆSee details»